Navigation Links
University of Leicester professor adds new perspective to rainforest debate
Date:10/17/2008

cientists in Brazil".

Conference participants came from Brazil, Chile, Argentina, Paraguay, Bolivia, Canada, the US, Finland and other countries.

The European Space Agency, NASA and the Brazilian Space Research Institute are currently studying possible new radar satellites.

The Eliasch review report to the prime minister Gordon Brown recently set out a British-led plan to set up a revolutionary multibillion pound to pay the owners of the world's rainforests for stopping deforestation. This fund is hoped to make a contribution to slowing down global warming. Reducing fossil fuel emissions is not enough to combat global warming. At the moment people emit more greenhouse gases than every before in the planet's history. Professor Balzter was one of only two scientists to be invited by the Office of Climate Change to be involved in the Eliasch review round table. More info at:

http://www.guardian.co.uk/politics/2008/oct/14/greenpolitics-climatechange


'/>"/>

Contact: Professor Heiko Balzter
acw4@le.ac.uk
44-011-625-23820
University of Leicester
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. University success at national engineering awards
2. Scent on demand: Hebrew University scientists enhance the scent of flowers
3. University professor stresses links between US Navy sonar and whale strandings
4. US Senate confirms Clemson University engineering Dean Esin Gulari to National Science Board
5. NIH selects Case Western Reserve University to participate in National Childrens Study
6. Brown University and Women & Infants Hospital expand national childrens study to Bristol County
7. Case Western Reserve University project ties soil conservation and river management together
8. Case Western Reserve University researchers track Chernobyl fallout
9. Rice University establishes National Corrosion Center
10. NSF funds multi-university center to study environmental implications of nanotechnology
11. NIH EUREKA grant awarded to University of Miami scientist
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6